ORAJEL

This brand name is authorized in United Kingdom, South Africa

Active ingredients

The drug ORAJEL contains one active pharmaceutical ingredient (API):

1 Benzocaine UNII U3RSY48JW5 - BENZOCAINE

Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited. Read about Benzocaine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ORAJEL Dental gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01BA05	Benzocaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BA Esters of aminobenzoic acid
Discover more medicines within N01BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 45104, 80638, 80654
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/4/0163